135 related articles for article (PubMed ID: 11289100)
21. CYP1A2 164 A-->C polymorphism, cigarette smoking, consumption of well-done red meat and risk of developing colorectal adenomas and carcinomas.
Saebø M; Skjelbred CF; Brekke Li K; Bowitz Lothe IM; Hagen PC; Johnsen E; Tveit KM; Kure EH
Anticancer Res; 2008; 28(4C):2289-95. PubMed ID: 18751408
[TBL] [Abstract][Full Text] [Related]
22. Association between allelic polymorphisms of metabolizing enzymes (CYP 1A1, CYP 1A2, CYP 2E1, mEH) and occurrence of colorectal cancer in Hungary.
Kiss I; Orsós Z; Gombos K; Bogner B; Csejtei A; Tibold A; Varga Z; Pázsit E; Magda I; Zölyomi A; Ember I
Anticancer Res; 2007; 27(4C):2931-7. PubMed ID: 17695473
[TBL] [Abstract][Full Text] [Related]
23. Microsomal epoxide hydrolase polymorphisms, cigarette smoking, and risk of colorectal cancer: the Fukuoka Colorectal Cancer Study.
Nisa H; Budhathoki S; Morita M; Toyomura K; Nagano J; Ohnaka K; Kono S; Ueki T; Tanaka M; Kakeji Y; Maehara Y; Okamura T; Ikejiri K; Futami K; Maekawa T; Yasunami Y; Takenaka K; Ichimiya H; Terasaka R
Mol Carcinog; 2013 Aug; 52(8):619-26. PubMed ID: 22415791
[TBL] [Abstract][Full Text] [Related]
24. Colorectal polyp type and the association with charred meat consumption, smoking, and microsomal epoxide hydrolase polymorphisms.
Burnett-Hartman AN; Newcomb PA; Mandelson MT; Adams SV; Wernli KJ; Shadman M; Wurscher MA; Makar KW
Nutr Cancer; 2011; 63(4):583-92. PubMed ID: 21598178
[TBL] [Abstract][Full Text] [Related]
25. NQO1 and mEH exon 4 (mEH4) gene polymorphisms, smoking and colorectal cancer risk.
Mitrou P; Watson M; Bingham S; Stebbings WS; Speakman CT; Loktionov A
IARC Sci Publ; 2002; 156():495-7. PubMed ID: 12484241
[No Abstract] [Full Text] [Related]
26. Risk of colorectal adenomas in relation to meat consumption, meat preparation, and genetic susceptibility in a Dutch population.
Tiemersma EW; Voskuil DW; Bunschoten A; Hogendoorn EA; Witteman BJ; Nagengast FM; Glatt H; Kok FJ; Kampman E
Cancer Causes Control; 2004 Apr; 15(3):225-36. PubMed ID: 15090717
[TBL] [Abstract][Full Text] [Related]
27. Role of genetic polymorphism of glutathione-S-transferase T1 and microsomal epoxide hydrolase in aflatoxin-associated hepatocellular carcinoma.
Tiemersma EW; Omer RE; Bunschoten A; van't Veer P; Kok FJ; Idris MO; Kadaru AM; Fedail SS; Kampman E
Cancer Epidemiol Biomarkers Prev; 2001 Jul; 10(7):785-91. PubMed ID: 11440964
[TBL] [Abstract][Full Text] [Related]
28. Oxidative Stress and Genetic Variants of Xenobiotic-Metabolising Enzymes Associated with COPD Development and Severity in Serbian Adults.
Malic Z; Topic A; Francuski D; Stankovic M; Nagorni-Obradovic L; Markovic B; Radojkovic D
COPD; 2017 Feb; 14(1):95-104. PubMed ID: 27421065
[TBL] [Abstract][Full Text] [Related]
29. Glutathione transferase (GSTM1) null genotype, smoking, and prevalence of colorectal adenomas.
Lin HJ; Probst-Hensch NM; Ingles SA; Han CY; Lin BK; Lee DB; Frankl HD; Lee ER; Longnecker MP; Haile RW
Cancer Res; 1995 Mar; 55(6):1224-6. PubMed ID: 7882312
[TBL] [Abstract][Full Text] [Related]
30. The effect of relevant genotypes on PAH exposure-related biomarkers.
Kuljukka-Rabb T; Nylund L; Vaaranrinta R; Savela K; Mutanen P; Veidebaum T; Sorsa M; Rannug A; Peltonen K
J Expo Anal Environ Epidemiol; 2002; 12(1):81-91. PubMed ID: 11859435
[TBL] [Abstract][Full Text] [Related]
31. Genetic polymorphisms of glutathione-S-transferase and microsomal epoxide hydrolase in egyptian acquired aplastic anemia patients.
Youssry I; Hammoud R; Ibrahim O; Youssef M; Beshlawy A
J Pediatr Hematol Oncol; 2011 Mar; 33(2):89-92. PubMed ID: 21228718
[TBL] [Abstract][Full Text] [Related]
32. Red meat intake, doneness, polymorphisms in genes that encode carcinogen-metabolizing enzymes, and colorectal cancer risk.
Cotterchio M; Boucher BA; Manno M; Gallinger S; Okey AB; Harper PA
Cancer Epidemiol Biomarkers Prev; 2008 Nov; 17(11):3098-107. PubMed ID: 18990750
[TBL] [Abstract][Full Text] [Related]
33. Glutathione S-transferase GSTM1 and GSTT1 polymorphisms and colorectal cancer risk: a prospective study.
Gertig DM; Stampfer M; Haiman C; Hennekens CH; Kelsey K; Hunter DJ
Cancer Epidemiol Biomarkers Prev; 1998 Nov; 7(11):1001-5. PubMed ID: 9829708
[TBL] [Abstract][Full Text] [Related]
34. Lung cancer susceptibility in relation to combined polymorphisms of microsomal epoxide hydrolase and glutathione S-transferase P1.
To-Figueras J; Gené M; Gómez-Catalán J; Piqué E; Borrego N; Corbella J
Cancer Lett; 2001 Nov; 173(2):155-62. PubMed ID: 11597790
[TBL] [Abstract][Full Text] [Related]
35. Cytochrome P4501A1 and microsomal epoxide hydrolase gene polymorphisms: gene-environment interaction and risk of prostate cancer.
Mittal RD; Srivastava DL
DNA Cell Biol; 2007 Nov; 26(11):791-8. PubMed ID: 17919073
[TBL] [Abstract][Full Text] [Related]
36. Cigarette smoking, genetic variants in carcinogen-metabolizing enzymes, and colorectal cancer risk.
Cleary SP; Cotterchio M; Shi E; Gallinger S; Harper P
Am J Epidemiol; 2010 Nov; 172(9):1000-14. PubMed ID: 20937634
[TBL] [Abstract][Full Text] [Related]
37. Effect of NAT1 and NAT2 genetic polymorphisms on colorectal cancer risk associated with exposure to tobacco smoke and meat consumption.
Lilla C; Verla-Tebit E; Risch A; Jäger B; Hoffmeister M; Brenner H; Chang-Claude J
Cancer Epidemiol Biomarkers Prev; 2006 Jan; 15(1):99-107. PubMed ID: 16434594
[TBL] [Abstract][Full Text] [Related]
38. Comparison of polymorphisms in genes involved in polycyclic aromatic hydrocarbon metabolism with urinary phenanthrene metabolite ratios in smokers.
Hecht SS; Carmella SG; Yoder A; Chen M; Li ZZ; Le C; Dayton R; Jensen J; Hatsukami DK
Cancer Epidemiol Biomarkers Prev; 2006 Oct; 15(10):1805-11. PubMed ID: 17035385
[TBL] [Abstract][Full Text] [Related]
39. High-activity microsomal epoxide hydrolase genotypes and the risk of oral, pharynx, and larynx cancers.
Jourenkova-Mironova N; Mitrunen K; Bouchardy C; Dayer P; Benhamou S; Hirvonen A
Cancer Res; 2000 Feb; 60(3):534-6. PubMed ID: 10676631
[TBL] [Abstract][Full Text] [Related]
40. Microsomal epoxide hydrolase and glutathione S-transferase polymorphisms in relation to laryngeal carcinoma risk.
To-Figueras J; Gené M; Gómez-Catalán J; Piqué E; Borrego N; Caballero M; Cruellas F; Raya A; Dicenta M; Corbella J
Cancer Lett; 2002 Dec; 187(1-2):95-101. PubMed ID: 12359356
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
